ARTICLE | Clinical News
GlycoMimetics preclinical data
December 24, 2012 8:00 AM UTC
In a mouse model of non-occlusive thrombosis, 10 mg/kg GMI-1271 significantly reduced venous thrombus formation vs. sham-treated controls (p=0.0271). The active control enoxaparin also significantly r...